New rules will make modern medications easier to access in Czechia

Patients in Czechia will soon find it easier to access modern treatments for chronic conditions as the Ministry of Health prepares to lift long-standing prescription restrictions.

Under a new decree expected to take effect this July, general practitioners (GPs) will finally be allowed to prescribe advanced medications that were previously reserved for specialists, reports iDnes.cz.

The change targets drugs for heart failure, diabetes, chronic kidney disease, and asthma. Currently, many of these "Group E" medications are only covered by public health insurance if prescribed by a cardiologist, nephrologist, or other specialist.

This has often forced patients to wait months for appointments or pay out of pocket to receive timely treatment.

"The discriminated against are mainly residents of remote areas, where the network of specialists is sparser," Petr Šonka, chairman of the Association of General Practitioners, told the publication. He described the current system as an "open-air museum of absurd restrictions" that forces unnecessary specialist visits for routine care.

Health Minister Adam Vojtěch confirmed the ministry is finalizing the decree, noting that expanding GP competencies is a crucial step in improving healthcare availability.

The move has received broad support from medical societies, which argue that the shift will free up specialists to handle more complex cases.

The human cost of the current bottleneck is particularly evident in kidney care. Experts note that a third of dialysis patients could significantly delay the need for transplants or dialysis if GPs could prescribe gliflozins (modern drugs that protect the heart and kidneys).

"This is just one example of the great inefficiency of the Czech healthcare system and the reason why we have one of the largest numbers of patient contacts with the healthcare system in the country," said general practitioner David Halata. 

"These medications have the greatest effect on young people whose diabetes has just been diagnosed," Halata added, noting that the six-month wait for a specialist appointment often condemns patients to lower-quality treatment during a critical window.

The change is particularly welcome for anyone who has registered with English-speaking general practitioners but hit a wall when anything beyond routine care is needed; specialist referrals are where language barriers and bureaucratic delays converge most painfully.

Under the current system, for instance, a newly diagnosed diabetic may wait months to see an endocrinologist before receiving modern first-line medication, while someone with poorly controlled asthma requires a pulmonologist referral for inhalers.

The reform aligns the country with standard practices in Western Europe, as well as neighbors like Poland and Romania.